As evidenced by the research conducted by Torres et al., IGFBP-4 has been implicated in the progression of PAH by driving vascular wall thickening through the promotion of pulmonary arterial vascular smooth muscle cell (VSMC) proliferation and the inhibition of apoptosis. The gene discussed is IGFBP4; the disease is pulmonary arterial hypertension.